Effects of long-acting risperidone vs olanzapine on metabolic parameters in patients with chronic schizophrenia

Trial Profile

Effects of long-acting risperidone vs olanzapine on metabolic parameters in patients with chronic schizophrenia

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2013

At a glance

  • Drugs Olanzapine; Risperidone
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top